bpc 157 and diverticulosis Diverticulitis BPC 157 Therapy and the
Description
Slowing the ramp to the label cadence (2.5 mg start, 2.5 mg steps, four-week holds) dropped that to mid-single digits at every maintenance dose, at no cost to the 12-week result, and the dedicated slow-titration trial reached placebo range. Reaching 15 mg is not the problem
Biophysics Rep
I've never tried subcutaneous but that may be a more suitable option for your daughter
Foot joints are especially vulnerable because they are cooler than other parts of the body and uric acid crystals are more likely to form in cooler environments
